Amgen To Present At The 2021 Jefferies Healthcare Conference

Rhea-AI Summary

Amgen (NASDAQ: AMGN) will present at the 2021 Jefferies Healthcare Conference on June 3, 2021, at 1:30 p.m. ET. Murdo Gordon, executive vice president of Global Commercial Operations, will lead the presentation. The conference call will be streamed live online, accessible to media, investors, and the public. Interested individuals can access the webcast on Amgen's website, where it will also be archived for 90 days.

Amgen specializes in innovative therapeutics and aims to meet high unmet medical needs, enhancing health outcomes globally.

THOUSAND OAKS, Calif., May 28, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2021 Jefferies Healthcare Conference at 1:30 p.m. ET on Thursday, June 3, 2021. Murdo Gordon, executive vice president of Global Commercial Operations at Amgen will present at the conference. Live audio of the conference call will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given at certain investor and medical conferences, can be accessed on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Michael Strapazon, 805-313-5553 (media) 
Arvind Sood, 805-447-1060 (investors) 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-2021-jefferies-healthcare-conference-301301907.html

SOURCE Amgen

FAQ

When will Amgen present at the 2021 Jefferies Healthcare Conference?

Amgen will present at the 2021 Jefferies Healthcare Conference on June 3, 2021, at 1:30 p.m. ET.

Who will present for Amgen at the Jefferies Healthcare Conference?

Murdo Gordon, executive vice president of Global Commercial Operations, will present for Amgen.

How can I listen to Amgen's presentation at the Jefferies Healthcare Conference?

The presentation can be streamed live on Amgen's website and will be available for at least 90 days after the event.

What is Amgen's focus in biotechnology?

Amgen focuses on developing innovative human therapeutics for serious illnesses with high unmet medical needs.

Where can I find more information about Amgen's events?

More information about Amgen's events is available on their Investor Relations Events Calendar on their website.